gallbladder, and the crossover in male-to-female ratio in squamous cell carcinoma along the digestive tract (i.e. from 6.0 at the level of the mouth/pharynx to 0.5 in the rectum). As concerns survival, rates were higher for lymphomas and sarcomas than for carcinomas in oral cavity and stomach, similar for carcinoids and carcinomas in the small bowel (about 35% at 5 years), as well as for colon (34%) and rectal (37%) cancers. Some of the findings, such as the higher survival of carcinomas arising from polyps in the colon and rectum, or the higher proportion of cholangiocellular and combined cholangio-and hepatocellular carcinomas in females than in males find plausible prognostic or aetiologic correlates, but others, such as the large proportions of squamous and transitional cell cancers of the rectum in females are more difficult to explain. These and several other indications emerging from careful examination of the data herein presented underline the interest of morphological analyses of digestive tract cancers.
In the scientific literature, cancer incidence registration and death certification statistics are usually reported by major sites , while more detailed analyses by different histotypes or other morphological entities are confined to reports whose circulation is relatively limited.
Such information, however, has potential importance for epidemiological and clinical research (Faivre et al., 1979a; Weber et al., 1980; Widgren, 1980; Blenkisopp et al., 1981; Levine et al., 1981; Mittal et al., 1983; Faivre et al., 1985; Cherie-Challine et Yang & Davis, 1989; Kimura et al., 1989) . For instance, various histotypes of the same cancer may recognise different aetiologies, and in a study or in a review of studies on risk factors, it is of interest to compare the distribution of histological types with that from population-based data. Similar problems may emerge in the analysis of clinical trials, since the morphological characteristics of a tumour may have important implications for evaluation of survival rates and, more in general, prognosis of the disease.
In the present report, therefore, we present absolute proportions, incidence, sex ratios and survival rates from the Cancer Registry of the Canton Vaud, Switzerland, for digestive sites, where detailed morphological distinctions and their variation according to age and sex has potential epidemiological and clinical relevance.
Material and methods
The data included in the present analysis were derived from the Vaud Cancer Registry datafile, which includes data concerning incident cases of malignant neoplasms in the Canton (whose population in 1980 was about 530,000 inhabitants) (Levi, 1987) . Population estimates are based on decennial censuses (1970, 1980) , and on estimates by the Cantonal Office of Statistics for each calendar year and 5 year age group, based on official numbers of births, deaths, immigrations and emigrations (Service Cantonal Table I .
Passive and active follow-up information is recorded and each subsequent item of information concerning an already registered case is used to complete the record of that patient. Information coming from death certificates is routinely added to the morbidity file. The vital status of each registered case has thus been verified up to June 30, 1989 .
Five-year crude survival probability and corresponding standard error were computed, for each topographical and morphological group, by means of the product-limit method (Peto et al., 1977) , starting from the date of histological (diagnostic) confirmation. For oesophageal cancer, a total of 545 incident cases were registered (397 males, 148 females), with incidence rates of 8.9/100,000 males and 2.4/100,000 females. In both sexes, squamous cell cancers accounted for over 70% of cases, adenocarcinomas for approximately 10% and other and unspecified histotypes for the remaining 15 to 20%. Herein however the sex ratio was apparently higher for adenocarcinomas as compared to squamous cell cancers (i.e., 11.0 vs 3.3).
Results
Among the 1,131 registered cases of stomach cancer (709 males, age-adjusted incidence rate 15.4/100,000; 422 females, 6.0/100,000), over 80% were adenocarcinomas, 5% lymphomas and 10% other and unspecified histotypes, these proportions being not appreciably different in the two sexes. Indeed, with the exception of the very rare sarcomas, the sex ratio was remarkably similar for each morphologic type, at variance with what reported for tumours of the mouth and pharynx.
There were 83 cases of small intestine cancer (45 males, 38 females), corresponding to an overall incidence of 0.7/100,000. Adenocarcinomas and infiltrating carcinoids accounted for 31% of cases each, sarcomas for 10% and lymphomas for 21% approximately (plus 7% other and unspecified), in the absence of significant differences in the two sexes. Highest sex ratios were recorded for adenocarcinomas and lymphomas (3.0 for both).
A total of 1,980 colon cancer cases were registered (941 males, incidence rate 20.0/100,000; 1,039 females, incidence rate 14.9/100,000). Adenocarcinoma was by far the most common histologic type, with 88% of cases in both sexes, plus 2.8% of adenocarcinomas arising in polyps or polyposis. There were 12 carcinoids, and over 130 other or unspecified histotypes. The male excess was moderate (global sex ratio = 1.2) and the sex ratio reversed for carcinoids (0.5).
Among the 1,267 rectal cancers (676 males, incidence rate 14.6/100,000; 591 females, incidence rate 9.3/100,000), 75% of cases in males and 65% in females were adenocarcinomas, and a further 16% in both sexes were adenocarcinomas in polyps or polyposis. Much more frequent in females that in males were squamous cell (7.1 vs 1.9% in males) and transitional cell cancers (5.9% vs 0.9%). Therefore the sex ratio was relatively high for adenocarcinomas (1.8) but below 1 for squamous and transitional cell cancers (0.5 and 0.2, respectively).
An appreciable proportion of the 357 liver cancers (over 25% in males and 40% in females) were purely clinical or of unspecified histotypes; among the histologically defined cancers, 66% in males and 38% in females were hepatocellular carcinomas, 9% in males and 22% in females cholangioor combined hepato-cholangiocellular carcinomas. The overall age-adjusted incidence was 5.9/100,000 males and 1.2/100,000 females. The sex ratio for the predominant morphological type (i.e., hepatocellular) was 9. indicates, for adenocarcinomas and overall, 30% lower incidence rates in males as compared to females.
Like in liver cancer, an appreciable proportion (over 30%) of the 725 pancreatic cancer cases were morphologically undefined. Among the histologically defined cases, 57% were adenocarcinomas and 2% islet cell carcinomas, these proportions being comparable in the two sexes. The age-standardised incidence rates were 8.5/100,000 males and 5.1/100,000 females. The category 'other carcinoma' showed the highest male-to-female ratio (3.0) whereas globally it was 1.7, the third lowest after cancers of the gallbladder and colon.
Comparable figures in two separate strata of age (under 60 and 60 and over) are given in Table III . Besides some systematic and probably real differences (i.e., lymphomas and sarcomas were proportionally more common in younger and middle ages as compared to older age), there was some apparent heterogeneity, which however can be attributed to more accurate case ascertainment in the young. This applies Table IV Age-and sex-specific incidence rates' and male-to-female ratios for cancers of the colon and rectum (Vaud, Switzerland, 1976 Age ( within carcinomas. Cases of small intestinal cancer had 5-year survival rates only marginally different (29%) from those of colon (34%) and rectum (37%), with similar rates for infiltrating carcinoids and adenocarcinomas. In the colon higher survival rates were observed for carcinoids (92%) and adenocarcinomas in polyps or polyposis (57%). In the rectum, too, survival rates were higher for cancers arising in polyps (53%), but no appreciable difference was observed between adenocarcinomas (35%), squamous (46%) or transitional cell carcinomas. Survival was extremely poor (under 10% at 5 years) for all cancers arising in the liver, gallbladder and pancreas, with the sole exception of the few islet cell carcinomas of the pancreas (34% 5 year rate).
Discussion
The present report has essentially a descriptive value, since it adds more detailed population-based information on incidence and survival rates than commonly available from cancer registration schemes. Most of its findings are already well recognised (Faivre et al., 1979a,b; Weber et al., 1980; Widgren, 1980; Blenkisopp et al., 1981; Levine et al., 1981; Mittal et al., 1983; Faivre et al., 1985; Cherie-Challine et al., 1988; Yang et al., 1988; Kimura et al., 1989) , and this article should essentially be viewed as a contribution towards the quantification, in a well surveilled population of the Westcentral part of Europe, of the proportional distribution of digestive neoplasms by morphological type, and corresponding incidence and survival rates. The high population coverage represents a major originality and reason of interest of the present study, although the accuracy of pathological diagnoses may be less precise than in some selected pathological series. Like in some nearby countries (i.e., France and Italy; Muir et al., 1987; Levi et al., 1989) , where the prevalence of smoking and high alcohol intake is elevated, cancers of the upper digestive tract (i.e., mouth, pharynx and oesophagus) represent in the Registry of Vaud a high fraction of digestive tract neoplasms (28% in males, 11% in females). Indeed, in comparison with 44 other European cancer registration areas (Levi et al., 1989) , incidence rates for cancers of the oral cavity and pharynx, and oesophagus rank seven and five, respectively, in males and six and 16 in females. The other digestive cancers are situated, in the European range, at intermediate-high levels, whereas incidence from gastric cancer is among the lowest in both sexes (Levi et al., 1989) .
The site-specific sex ratios of mortality in Switzerland have already been reviewed (La Vecchia & Levi, 1988) and also here do not differ substantially from other European countries (Levi et al., 1989) (with the possible exception of a particularly notable male excess in gastric cancer incidence). A careful assessment of different morphological types, however, reveals some still largely unappreciated features. The highest male-to-female ratios are found in squamous cell carcinomas of the mouth and pharynx, adenocarcinomas of the oesophagus, and hepatocellular carcinomas, the lowest ones not only in infiltrating carcinoids of the colon and gallbladder adenocarcinomas, in which a female excess is well recognised Peter et al., 1990) , but also in transitional and squamous cell carcinomas of the rectum. Although drawing aetiological conclusions remains difficult (e.g., involvement of squamous-cell tropic viruses common in the female low genital tract, such as papillomavirus; Zur Hausen, 1989) , it is, in any case, worth noting that the male-to-female ratio in squamous cell cancers shows a tendency to decrease along the digestive tract: from 6.0 in the oral cavity and pharynx to 0.5 in the rectum.
Age-specific incidence rates of colon cancer for Caucasian women are generally equal or higher than those for men before the sixth decade, after which the rates for men exceed those for women (McMichael & Potter, 1980; Faivre et al., 1989; Zaridze & Filipchenko, 1990; Peters et al., 1990) . Kune et al. (1986) developed regression log-linear models to analyse the relationship between sex and incidence rates for five colorectal subsites, and suggested that the increasing male-to-female ratio with the increasing distance down the large bowel is related to the earlier age at which the male excess occurs the further the distance down the bowel. Although utmost caution is suggested by the difficulties in classifying bowel cancer subsites correctly, data from the Registry of Vaud support the possibility that the male excess is greater for rectal cancer at older ages.
Besides the descriptive aspects, there are a few points which deserve specific attention. Among these, there is the confirmation of higher survival rates of lymphomas as compared to carcinomas of the stomach and, perhaps, of the oral cavity (Mittal et al., 1983) ; among small bowel cancers, the proportion of infiltrating carcinoids is similar to that of adenocarcinomas and the survival rate for these two histotypes is comparable (approximately 35% at 5 years); overall, survival from small bowel cancers (29% at 5 years) is only slightly lower than for the globality of colon (34%) or rectal (37%) cancers. In relation to large bowel cancers, survival was, as expected, higher for carcinomas arising on polyps, but there is, to our knowledge, no simple explanation for the larger proportion of squamous and transitional cell cancers in females (although this has not important prognostic implications).
The elevated proportion of undefined histological types for liver and pancreatic cancers underlines the difficulties of precise case ascertainment and classification for these neoplasms (Doll & Peto, 1981) , even in a highly integrated and monitored population-based scheme.
The higher frequency of cholangio-and hepatocellular carcinomas combined in females than in males probably reflects similarities of aetiological correlates with gallbladder cancer, although the issue is still discussed (Strom et al., 1985) , Prognosis was extremely poor for all neoplasms arising from liver, gallbladder and pancreas (Propok, 1978; Levine et al., 1981; Doll & Peto, 1981; Cairns & Boyle, 1983; American Cancer Society, 1988) , but there was some suggestion that intrahepatic cholangiocellular carcinomas have lower survival than gallbladder cancers.
These and several other indications emerging from careful examination of the data presented herein underline the interest of morphological analyses of digestive tract neoplasms, in terms of descriptive epidemiology, inference on aetiological correlates and prognostic implications.
